Top Key Companies for Molecular Point-of-Care Testing Market: Roche Molecular Diagnostics, Salignostics, Saw Diagnostics, Siemens Healthineer, Sona Nanotech, T2 Biosystems, Talis Biomedical, Thermo Fisher Scientific Inc., Veramarx, XCR Diagnostics, Zhejiang Orient Gene Biotech.
Global Molecular Point-of-Care Testing Market Size was estimated at USD 686.8 million in 2022 and is projected to reach USD 1095.93 million by 2028, exhibiting a CAGR of 8.1% during the forecast period.
Global Molecular Point-of-Care Testing Market Overview And Scope:
The Global Molecular Point-of-Care Testing Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Molecular Point-of-Care Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Molecular Point-of-Care Testing Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Point-of-Care Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Molecular Point-of-Care Testing market.
Global Molecular Point-of-Care Testing Market Segmentation
By Type, Molecular Point-of-Care Testing market has been segmented into:
Polymerase Chain Reaction (PCR)
Loop-mediated Isothermal Amplification (LAMP)
Nucleic Acid Sequence-based Amplification (NASBA)
By Application, Molecular Point-of-Care Testing market has been segmented into:
Infectious Diseases
Genetic Disorders
Pregnancy Testing
Diagnosis of Cancer
Pharmacogenomics
Regional Analysis of Molecular Point-of-Care Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Molecular Point-of-Care Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Molecular Point-of-Care Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Molecular Point-of-Care Testing market.
Top Key Companies Covered in Molecular Point-of-Care Testing market are:
Roche Molecular Diagnostics
Salignostics
Saw Diagnostics
Siemens Healthineer
Sona Nanotech
T2 Biosystems
Talis Biomedical
Thermo Fisher Scientific Inc.
Veramarx
XCR Diagnostics
Zhejiang Orient Gene Biotech
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Molecular Point-of-Care Testing Market by Type
5.1 Molecular Point-of-Care Testing Market Overview Snapshot and Growth Engine
5.2 Molecular Point-of-Care Testing Market Overview
5.3 Polymerase Chain Reaction (PCR)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Polymerase Chain Reaction (PCR): Geographic Segmentation
5.4 Loop-mediated Isothermal Amplification (LAMP)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Loop-mediated Isothermal Amplification (LAMP): Geographic Segmentation
5.5 Nucleic Acid Sequence-based Amplification (NASBA)
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Nucleic Acid Sequence-based Amplification (NASBA): Geographic Segmentation
Chapter 6: Molecular Point-of-Care Testing Market by Application
6.1 Molecular Point-of-Care Testing Market Overview Snapshot and Growth Engine
6.2 Molecular Point-of-Care Testing Market Overview
6.3 Infectious Diseases
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Infectious Diseases: Geographic Segmentation
6.4 Genetic Disorders
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Genetic Disorders: Geographic Segmentation
6.5 Pregnancy Testing
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Pregnancy Testing: Geographic Segmentation
6.6 Diagnosis of Cancer
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Diagnosis of Cancer: Geographic Segmentation
6.7 Pharmacogenomics
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2026-2035F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Pharmacogenomics: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Molecular Point-of-Care Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Molecular Point-of-Care Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Molecular Point-of-Care Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ROCHE MOLECULAR DIAGNOSTICS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SALIGNOSTICS
7.4 SAW DIAGNOSTICS
7.5 SIEMENS HEALTHINEER
7.6 SONA NANOTECH
7.7 T2 BIOSYSTEMS
7.8 TALIS BIOMEDICAL
7.9 THERMO FISHER SCIENTIFIC INC.
7.10 VERAMARX
7.11 XCR DIAGNOSTICS
7.12 ZHEJIANG ORIENT GENE BIOTECH
Chapter 8: Global Molecular Point-of-Care Testing Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Polymerase Chain Reaction (PCR)
8.2.2 Loop-mediated Isothermal Amplification (LAMP)
8.2.3 Nucleic Acid Sequence-based Amplification (NASBA)
8.3 Historic and Forecasted Market Size By Application
8.3.1 Infectious Diseases
8.3.2 Genetic Disorders
8.3.3 Pregnancy Testing
8.3.4 Diagnosis of Cancer
8.3.5 Pharmacogenomics
Chapter 9: North America Molecular Point-of-Care Testing Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Polymerase Chain Reaction (PCR)
9.4.2 Loop-mediated Isothermal Amplification (LAMP)
9.4.3 Nucleic Acid Sequence-based Amplification (NASBA)
9.5 Historic and Forecasted Market Size By Application
9.5.1 Infectious Diseases
9.5.2 Genetic Disorders
9.5.3 Pregnancy Testing
9.5.4 Diagnosis of Cancer
9.5.5 Pharmacogenomics
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Molecular Point-of-Care Testing Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Polymerase Chain Reaction (PCR)
10.4.2 Loop-mediated Isothermal Amplification (LAMP)
10.4.3 Nucleic Acid Sequence-based Amplification (NASBA)
10.5 Historic and Forecasted Market Size By Application
10.5.1 Infectious Diseases
10.5.2 Genetic Disorders
10.5.3 Pregnancy Testing
10.5.4 Diagnosis of Cancer
10.5.5 Pharmacogenomics
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Molecular Point-of-Care Testing Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Polymerase Chain Reaction (PCR)
11.4.2 Loop-mediated Isothermal Amplification (LAMP)
11.4.3 Nucleic Acid Sequence-based Amplification (NASBA)
11.5 Historic and Forecasted Market Size By Application
11.5.1 Infectious Diseases
11.5.2 Genetic Disorders
11.5.3 Pregnancy Testing
11.5.4 Diagnosis of Cancer
11.5.5 Pharmacogenomics
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Molecular Point-of-Care Testing Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Polymerase Chain Reaction (PCR)
12.4.2 Loop-mediated Isothermal Amplification (LAMP)
12.4.3 Nucleic Acid Sequence-based Amplification (NASBA)
12.5 Historic and Forecasted Market Size By Application
12.5.1 Infectious Diseases
12.5.2 Genetic Disorders
12.5.3 Pregnancy Testing
12.5.4 Diagnosis of Cancer
12.5.5 Pharmacogenomics
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Molecular Point-of-Care Testing Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Polymerase Chain Reaction (PCR)
13.4.2 Loop-mediated Isothermal Amplification (LAMP)
13.4.3 Nucleic Acid Sequence-based Amplification (NASBA)
13.5 Historic and Forecasted Market Size By Application
13.5.1 Infectious Diseases
13.5.2 Genetic Disorders
13.5.3 Pregnancy Testing
13.5.4 Diagnosis of Cancer
13.5.5 Pharmacogenomics
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Molecular Point-of-Care Testing Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Polymerase Chain Reaction (PCR)
14.4.2 Loop-mediated Isothermal Amplification (LAMP)
14.4.3 Nucleic Acid Sequence-based Amplification (NASBA)
14.5 Historic and Forecasted Market Size By Application
14.5.1 Infectious Diseases
14.5.2 Genetic Disorders
14.5.3 Pregnancy Testing
14.5.4 Diagnosis of Cancer
14.5.5 Pharmacogenomics
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Molecular Point-of-Care Testing Scope:
|
Report Data
|
Molecular Point-of-Care Testing Market
|
|
Molecular Point-of-Care Testing Market Size in 2025
|
USD XX million
|
|
Molecular Point-of-Care Testing CAGR 2025 - 2032
|
XX%
|
|
Molecular Point-of-Care Testing Base Year
|
2024
|
|
Molecular Point-of-Care Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche Molecular Diagnostics, Salignostics, Saw Diagnostics, Siemens Healthineer, Sona Nanotech, T2 Biosystems, Talis Biomedical, Thermo Fisher Scientific Inc., Veramarx, XCR Diagnostics, Zhejiang Orient Gene Biotech.
|
|
Key Segments
|
By Type
Polymerase Chain Reaction (PCR)
Loop-mediated Isothermal Amplification (LAMP)
Nucleic Acid Sequence-based Amplification (NASBA)
By Applications
Infectious Diseases
Genetic Disorders
Pregnancy Testing
Diagnosis of Cancer
Pharmacogenomics
|
